Li, Likang
Lip, Gregory Y. H.
Li, Shuai
Adachi, Jonathan D.
Thabane, Lehana
Li, Guowei
Funding for this research was provided by:
Science Foundation of Guangdong Second Provincial General Hospital (YY2018-002)
National Natural Science Foundation of China (82103906)
Article History
Received: 26 April 2022
Accepted: 8 July 2022
First Online: 15 July 2022
Declarations
:
: The UK Biobank study was approved by the North West Multicenter Research Ethics Committee (11/NW/0382). The Guangdong Second General Provincial Hospital Research Ethics Committee approved the current analysis (2022-KY-KZ-119-01). All participants provided written consent before enrolment.
: Consent for publication was obtained from all authors.
: GYHL has served as a consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No fees have been received directly or personally. All other authors have declared no conflicts of interest.